GraniteShares has rolled out four new ETFs under its YieldBOOST platform, aiming to tap investor demand for high-frequency income strategies tied to high-conviction market themes.

The ETFs offering exposure to biotech, financials, technology, and long-duration Treasuries through options-based strategies built on 3x leveraged instruments:

• GraniteShares YieldBOOST Biotech ETF (NASDAQ:BIOY),
• GraniteShares YieldBOOST Financials ETF (NASDAQ:FINY),
• GraniteShares YieldBOOST Technology ETF (NASDAQ:TECY), and
• GraniteShares YieldBOOST 20Y+ Treasuries ETF (NASDAQ:FIYY)

The firm designed the funds to generate weekly income by writing put options on leveraged ETFs tracking benchmarks such as the S&P Biotechnology Select Industry Index, Financial Select Sector Index, Technology Select Sector Index, and the ICE U.S. Treasury 20+ Year Bond Index.

GraniteShares CEO Will Rhind said the strategy seeks to harness elevated implied volatility in leveraged products to enhance income potential, though distributions are not guaranteed.

Key Features

• Options-driven weekly income: Each fund primarily sells put options on 3x leveraged ETFs to capture higher premiums from volatility
• Sector-focused exposure: Targets biotech (BIOY), financials (FINY), and technology (TECY), alongside long-duration bonds (FIYY)
• High volatility angle: Strategies aim to benefit from sectors with structurally elevated implied volatility, such as biotech and rate-sensitive Treasuries
• Alternative to traditional income: Designed for investors seeking yield beyond conventional dividend or bond strategies
• Indirect leveraged exposure: While not directly holding leveraged ETFs, income is derived from options tied to those instruments

The launch builds on GraniteShares' push into income-oriented ETFs, leveraging its expertise in high-conviction and leveraged strategies, with $11.58 billion in assets under management as of late April.

Image: Shutterstock